{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T08:55:36Z","timestamp":1792659336890,"version":"4.5.0"},"reference-count":80,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1097\/mnh.0b013e3281ca6ffd","type":"journal-article","created":{"date-parts":[[2007,6,12]],"date-time":"2007-06-12T08:03:36Z","timestamp":1181635416000},"page":"329-335","source":"Crossref","is-referenced-by-count":104,"title":["Emerging role of fibroblast growth factor 23 in a bone\u2013kidney axis regulating systemic phosphate homeostasis and extracellular matrix mineralization"],"prefix":"10.1097","volume":"16","author":[{"given":"Shiguang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditi","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L Darryl","family":"Quarles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20210205","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1006\/bbrc.2000.3696","article-title":"Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain","volume":"277","author":"Yamashita","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"R2-8-20210205","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1744-9987.2005.00288.x","article-title":"Structural and biochemical properties of fibroblast growth factor 23","volume":"9","author":"Yamashita","year":"2005","journal-title":"Ther Apher Dial"},{"key":"R3-8-20210205","doi-asserted-by":"crossref","first-page":"5269","DOI":"10.1210\/en.2004-0233","article-title":"Transgenic mice overexpressing human fibroblast growth factor 23 (R176Q) delineate a putative role for parathyroid hormone in renal phosphate wasting disorders","volume":"145","author":"Bai","year":"2004","journal-title":"Endocrinology"},{"key":"R4-8-20210205","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1210\/en.2003-1768","article-title":"Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis","volume":"145","author":"Larsson","year":"2004","journal-title":"Endocrinology"},{"key":"R5-8-20210205","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.bbrc.2003.12.102","article-title":"FGF-23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type IIa","volume":"314","author":"Shimada","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"R6-8-20210205","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.matbio.2004.09.007","article-title":"Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice","volume":"23","author":"Sitara","year":"2004","journal-title":"Matrix Biol"},{"key":"R7-8-20210205","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1172\/JCI200419081","article-title":"Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism","volume":"113","author":"Shimada","year":"2004","journal-title":"J Clin Invest"},{"key":"R8-8-20210205","doi-asserted-by":"crossref","first-page":"E38","DOI":"10.1152\/ajpendo.00008.2006","article-title":"Pathogenic role of Fgf23 in Hyp mice","volume":"291","author":"Liu","year":"2006","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"R9-8-20210205","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/81664","article-title":"Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23.","volume":"26","year":"2000","journal-title":"Nat Genet"},{"key":"R10-8-20210205","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1046\/j.1523-1755.2001.00064.x","article-title":"Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23","volume":"60","author":"White","year":"2001","journal-title":"Kidney Int"},{"key":"R11-8-20210205","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1359\/jbmr.2003.18.7.1227","article-title":"Serum FGF23 levels in normal and disordered phosphorus homeostasis","volume":"18","author":"Weber","year":"2003","journal-title":"J Bone Miner Res"},{"key":"R12-8-20210205","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1210\/jc.2002-021105","article-title":"Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets\/osteomalacia","volume":"87","author":"Yamazaki","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"R13-8-20210205","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1681\/ASN.2004121060","article-title":"Role of matrix extracellular phosphoglycoprotein in the pathogenesis of X-linked hypophosphatemia","volume":"16","author":"Liu","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R14-8-20210205","first-page":"S16","article-title":"The Neutralization of FGF-23 ameliorates hypophosphatemia and richkets in Hyp mice [abstract]","volume":"18","author":"Aono","year":"2003","journal-title":"J Bone Miner Res"},{"key":"R15-8-20210205","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/ng1095-130","article-title":"A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets.","volume":"11","year":"1995","journal-title":"Nat Genet"},{"key":"R16-8-20210205","first-page":"355","article-title":"The PEX gene: its role in X-linked rickets, osteomalacia, and bone mineral metabolism","volume":"5","author":"Rowe","year":"1997","journal-title":"Exp Nephrol"},{"key":"R17-8-20210205","first-page":"F357","article-title":"X-linked hypophosphatemic rickets and the murine Hyp homologue","volume":"268","author":"Hruska","year":"1995","journal-title":"Am J Physiol"},{"key":"R18-8-20210205","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/ng1905","article-title":"Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism","volume":"38","author":"Feng","year":"2006","journal-title":"Nat Genet"},{"key":"R19-8-20210205","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/ng1868","article-title":"DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone matrix protein in the regulation of phosphate homeostasis","volume":"38","author":"Lorenz-Depiereux","year":"2006","journal-title":"Nat Genet"},{"key":"R20-8-20210205","doi-asserted-by":"crossref","first-page":"6500","DOI":"10.1073\/pnas.101545198","article-title":"Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia","volume":"98","author":"Shimada","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R21-8-20210205","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1210\/jc.2004-0357","article-title":"Fibroblast growth factor 7: an inhibitor of phosphate transport derived from oncogenic osteomalacia-causing tumors","volume":"90","author":"Carpenter","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"R22-8-20210205","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1006\/geno.2000.6235","article-title":"MEPE, a new gene expressed in bone marrow and tumors causing osteomalacia","volume":"67","author":"Rowe","year":"2000","journal-title":"Genomics"},{"key":"R23-8-20210205","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1172\/JCI18399","article-title":"FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting","volume":"112","author":"Riminucci","year":"2003","journal-title":"J Clin Invest"},{"key":"R24-8-20210205","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/ajmg.a.30915","article-title":"Skeletal changes in epidermal nevus syndrome: does focal bone disease harbor clues concerning pathogenesis?","volume":"139","author":"Heike","year":"2005","journal-title":"Am J Med Genet A"},{"key":"R25-8-20210205","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1086\/508069","article-title":"A deleterious mutation in SAMD9 causes normophosphatemic familial tumoral calcinosis","volume":"79","author":"Topaz","year":"2006","journal-title":"Am J Hum Genet"},{"key":"R26-8-20210205","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/hmg\/ddi034","article-title":"An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia","volume":"14","author":"Benet-Pages","year":"2005","journal-title":"Hum Mol Genet"},{"key":"R27-8-20210205","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1042\/bj20030287","article-title":"Human recombinant endopeptidase PHEX has a strict S1\u2019 specificity for acidic residues and cleaves peptides derived from fibroblast growth factor-23 and matrix extracellular phosphoglycoprotein","volume":"373","author":"Campos","year":"2003","journal-title":"Biochem J"},{"key":"R28-8-20210205","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.bone.2004.04.002","article-title":"FGF23 is processed by proprotein convertases but not by PHEX","volume":"35","author":"Benet-Pages","year":"2004","journal-title":"Bone"},{"key":"R29-8-20210205","doi-asserted-by":"crossref","first-page":"37419","DOI":"10.1074\/jbc.M304544200","article-title":"Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX","volume":"278","author":"Liu","year":"2003","journal-title":"J Biol Chem"},{"key":"R30-8-20210205","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.1074\/jbc.M107707200","article-title":"Overexpression of Phex in osteoblasts fails to rescue the Hyp mouse phenotype","volume":"277","author":"Liu","year":"2002","journal-title":"J Biol Chem"},{"key":"R31-8-20210205","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1210\/me.2002-0113","article-title":"Partial rescue of the Hyp phenotype by osteoblast-targeted PHEX (phosphate-regulating gene with homologies to endopeptidases on the X chromosome) expression","volume":"16","author":"Bai","year":"2002","journal-title":"Mol Endocrinol"},{"key":"R32-8-20210205","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1177\/154405910308201003","article-title":"The Dentin matrix protein 1 (Dmp1) is specifically expressed in mineralized, but not soft, tissues during development","volume":"82","author":"Feng","year":"2003","journal-title":"J Dent Res"},{"key":"R33-8-20210205","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.bone.2004.03.006","article-title":"Dentin matrix protein 1 expression during osteoblastic differentiation, generation of an osteocyte GFP-transgene","volume":"35","author":"Kalajzic","year":"2004","journal-title":"Bone"},{"key":"R34-8-20210205","doi-asserted-by":"crossref","first-page":"18115","DOI":"10.1074\/jbc.M314114200","article-title":"In vitro effects of dentin matrix protein-1 on hydroxyapatite formation provide insights into in vivo functions","volume":"279","author":"Tartaix","year":"2004","journal-title":"J Biol Chem"},{"issue":"Suppl 1","key":"R35-8-20210205","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1080\/03008200390181726","article-title":"Dentin matrix protein 1 initiates hydroxyapatite formation in vitro","volume":"44","author":"He","year":"2003","journal-title":"Connect Tissue Res"},{"key":"R36-8-20210205","doi-asserted-by":"crossref","first-page":"5358","DOI":"10.1210\/en.2005-0777","article-title":"Dietary and serum phosphorus regulate fibroblast growth factor 23 expression and 1,25-dihydroxyvitamin D metabolism in mice","volume":"146","author":"Perwad","year":"2005","journal-title":"Endocrinology"},{"key":"R37-8-20210205","doi-asserted-by":"crossref","first-page":"18478","DOI":"10.1074\/jbc.M213021200","article-title":"Paired basic\/Furin-like proprotein convertase cleavage of Pro-BMP-1 in the trans-Golgi network","volume":"278","author":"Leighton","year":"2003","journal-title":"J Biol Chem"},{"key":"R38-8-20210205","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1074\/jbc.M203250200","article-title":"Targeted disruption of the osteoblast\/osteocyte factor 45 gene (OF45) results in increased bone formation and bone mass","volume":"278","author":"Gowen","year":"2003","journal-title":"J Biol Chem"},{"key":"R39-8-20210205","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1006\/geno.2001.6553","article-title":"Mepe, the gene encoding a tumor-secreted protein in oncogenic hypophosphatemic osteomalacia, is expressed in bone","volume":"74","author":"Argiro","year":"2001","journal-title":"Genomics"},{"key":"R40-8-20210205","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1359\/jbmr.2001.16.11.2017","article-title":"Dentin matrix protein 1 is predominantly expressed in chicken and rat osteocytes but not in osteoblasts","volume":"16","author":"Toyosawa","year":"2001","journal-title":"J Bone Miner Res"},{"key":"R41-8-20210205","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.bone.2003.10.005","article-title":"MEPE has the properties of an osteoblastic phosphatonin and minhibin","volume":"34","author":"Rowe","year":"2004","journal-title":"Bone"},{"key":"R42-8-20210205","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1210\/jc.2003-032031","article-title":"Serum levels of matrix extracellular phosphoglycoprotein (MEPE) in normal humans correlate with serum phosphorus, parathyroid hormone and bone mineral density","volume":"89","author":"Jain","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"R43-8-20210205","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.bone.2004.09.015","article-title":"Surface plasmon resonance (SPR) confirms that MEPE binds to PHEX via the MEPE-ASARM motif: a model for impaired mineralization in X-linked rickets (HYP)","volume":"36","author":"Rowe","year":"2005","journal-title":"Bone"},{"key":"R44-8-20210205","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1677\/joe.1.07059","article-title":"Phosphorylated acidic serine-aspartate-rich MEPE-associated motif peptide from matrix extracellular phosphoglycoprotein inhibits phosphate regulating gene with homologies to endopeptidases on the X-chromosome enzyme activity","volume":"192","author":"Liu","year":"2007","journal-title":"J Endocrinol"},{"key":"R45-8-20210205","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1074\/jbc.M408903200","article-title":"Circulating FGF-23 is regulated by 1alpha,25-dihydroxyvitamin D3 and phosphorus in vivo","volume":"280","author":"Saito","year":"2005","journal-title":"J Biol Chem"},{"key":"R46-8-20210205","doi-asserted-by":"crossref","first-page":"E1101","DOI":"10.1152\/ajpendo.00502.2004","article-title":"Vitamin D and phosphate regulate fibroblast growth factor-23 in K-562 cells","volume":"288","author":"Ito","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"R47-8-20210205","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1210\/jc.2006-0021","article-title":"Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men","volume":"91","author":"Antoniucci","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"R48-8-20210205","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1359\/jbmr.060507","article-title":"Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women","volume":"21","author":"Burnett","year":"2006","journal-title":"J Bone Miner Res"},{"key":"R49-8-20210205","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1210\/jc.2004-1039","article-title":"Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men","volume":"90","author":"Ferrari","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"R50-8-20210205","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1046\/j.1523-1755.2003.00328.x","article-title":"Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers","volume":"64","author":"Larsson","year":"2003","journal-title":"Kidney Int"},{"key":"R51-8-20210205","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/JBMR.0301264","article-title":"FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis","volume":"19","author":"Shimada","year":"2004","journal-title":"J Bone Miner Res"},{"key":"R52-8-20210205","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1681\/ASN.2005111185","article-title":"Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D","volume":"17","author":"Liu","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"R53-8-20210205","doi-asserted-by":"crossref","first-page":"G1036","DOI":"10.1152\/ajpgi.00243.2005","article-title":"1alpha,25-Dihydroxyvitamin D3 upregulates FGF23 gene expression in bone: the final link in a renal\u2013gastrointestinal\u2013skeletal axis that controls phosphate transport","volume":"289","author":"Kolek","year":"2005","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"R54-8-20210205","doi-asserted-by":"crossref","first-page":"46406","DOI":"10.1074\/jbc.M404278200","article-title":"1,25-dihydroxyvitamin D3 down-regulation of PHEX gene expression is mediated by apparent repression of a 110 kDa transfactor that binds to a polyadenine element in the promoter","volume":"279","author":"Hines","year":"2004","journal-title":"J Biol Chem"},{"key":"R55-8-20210205","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.bone.2005.03.002","article-title":"Genetic dissection of phosphate- and vitamin D-mediated regulation of circulating Fgf23 concentrations","volume":"36","author":"Yu","year":"2005","journal-title":"Bone"},{"key":"R56-8-20210205","doi-asserted-by":"crossref","first-page":"F1088","DOI":"10.1152\/ajprenal.00474.2004","article-title":"Vitamin D receptor-independent FGF23 actions in regulating phosphate and vitamin D metabolism","volume":"289","author":"Shimada","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"key":"R57-8-20210205","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1042\/BJ20041799","article-title":"Role of the vitamin D receptor in FGF23 action on phosphate metabolism","volume":"390","author":"Inoue","year":"2005","journal-title":"Biochem J"},{"key":"R58-8-20210205","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1172\/JCI29463","article-title":"Vitamin D receptor in chondrocytes promotes osteoclastogenesis and regulates FGF23 production in osteoblasts","volume":"116","author":"Masuyama","year":"2006","journal-title":"J Clin Invest"},{"key":"R59-8-20210205","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000093277","article-title":"FGF-23 and sFRP-4 in chronic kidney disease and post-renal transplantation","volume":"104","author":"Pande","year":"2006","journal-title":"Nephron Physiol"},{"key":"R60-8-20210205","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1681\/ASN.2005010052","article-title":"Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease","volume":"16","author":"Gutierrez","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R61-8-20210205","doi-asserted-by":"crossref","first-page":"6120","DOI":"10.1074\/jbc.C500457200","article-title":"Regulation of fibroblast growth factor-23 signaling by klotho","volume":"281","author":"Kurosu","year":"2006","journal-title":"J Biol Chem"},{"key":"R62-8-20210205","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/nature05315","article-title":"Klotho converts canonical FGF receptor into a specific receptor for FGF23","volume":"444","author":"Urakawa","year":"2006","journal-title":"Nature"},{"key":"R63-8-20210205","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/36285","article-title":"Mutation of the mouse klotho gene leads to a syndrome resembling ageing","volume":"390","author":"Kuro-o","year":"1997","journal-title":"Nature"},{"key":"R64-8-20210205","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1247\/csf.29.91","article-title":"Immunohistochemical localization of Klotho protein in brain, kidney, and reproductive organs of mice","volume":"29","author":"Li","year":"2004","journal-title":"Cell Struct Funct"},{"key":"R65-8-20210205","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1074\/jbc.M207872200","article-title":"Human fibroblast growth factor-23 mutants suppress Na+-dependent phosphate co-transport activity and 1alpha,25-dihydroxyvitamin D3 production","volume":"278","author":"Saito","year":"2003","journal-title":"J Biol Chem"},{"key":"R66-8-20210205","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1101\/gad.1276205","article-title":"Unique coexpression in osteoblasts of broadly expressed genes accounts for the spatial restriction of ECM mineralization to bone","volume":"19","author":"Murshed","year":"2005","journal-title":"Genes Dev"},{"key":"R67-8-20210205","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","article-title":"Mineral metabolism, mortality, and morbidity in maintenance hemodialysis","volume":"15","author":"Block","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"R68-8-20210205","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1093\/ndt\/gfg414","article-title":"Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality","volume":"18","author":"London","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"R69-8-20210205","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1038\/sj.ki.5001788","article-title":"Posttransplant hypophosphatemia: tertiary \u2018hyper-phosphatoninism\u2019?","volume":"70","author":"Bhan","year":"2006","journal-title":"Kidney Int"},{"key":"R70-8-20210205","first-page":"A","article-title":"Fibroblast growth factor-23 (FGF-23) relationship to oral phosphate load in CKD patients undergoing hemodialysis therapy [abstract].","volume":"758","author":"Shigematsu","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R71-8-20210205","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/sj.ki.5000020","article-title":"Effect of manipulating serum phosphorus with phosphate binder on circulating PTH and FGF23 in renal failure rats","volume":"69","author":"Nagano","year":"2006","journal-title":"Kidney Int"},{"key":"R72-8-20210205","doi-asserted-by":"crossref","first-page":"c94","DOI":"10.1159\/000086347","article-title":"Intravenous calcitriol therapy increases serum concentrations of fibroblast growth factor-23 in dialysis patients with secondary hyperparathyroidism","volume":"101","author":"Nishi","year":"2005","journal-title":"Nephron Clin Pract"},{"key":"R74-8-20210205","first-page":"A","article-title":"FGF-23 levels decline to within normal range in the first 5 days post-transplant [abstract].","volume":"694","author":"Wesseling","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"R75-8-20210205","first-page":"A","article-title":"Post-renal transplantation hypophosphatemia: natural history and pathogenesis [abstract].","volume":"758","author":"Ghanekar","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R76-8-20210205","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1007\/s00467-006-0230-3","article-title":"FGF23: its role in renal bone disease","volume":"21","author":"Fukagawa","year":"2006","journal-title":"Pediatr Nephrol"},{"key":"R77-8-20210205","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/S0272-6386(12)80614-7","article-title":"Uremic tumoral calcinosis: preliminary observations suggesting an association with aberrant vitamin D homeostasis","volume":"18","author":"Quarles","year":"1991","journal-title":"Am J Kidney Dis"},{"key":"R79-8-20210205","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.matbio.2006.10.003","article-title":"Ablation of vitamin D signaling rescues bone, mineral, and glucose homeostasis in Fgf-23 deficient mice","volume":"26","author":"Hesse","year":"2007","journal-title":"Matrix Biol"},{"key":"R80-8-20210205","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.2353\/ajpath.2006.060329","article-title":"Genetic ablation of vitamin dactivation pathway reverses biochemical and skeletal anomalies in fgf-23-null animals","volume":"169","author":"Sitara","year":"2006","journal-title":"Am J Pathol"},{"key":"R81-8-20210205","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/sj.ki.5001514","article-title":"Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients","volume":"70","author":"Kalantar-Zadeh","year":"2006","journal-title":"Kidney Int"},{"key":"R82-8-20210205","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1681\/ASN.2004070573","article-title":"Activated injectable vitamin D and hemodialysis survival: a historical cohort study","volume":"16","author":"Teng","year":"2005","journal-title":"J Am Soc Nephrol"}],"container-title":["Current Opinion in Nephrology & Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MNH.0b013e3281ca6ffd","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:24:55Z","timestamp":1620962695000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00041552-200707000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":80,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/mnh.0b013e3281ca6ffd","relation":{},"ISSN":["1062-4821"],"issn-type":[{"value":"1062-4821","type":"print"}],"subject":[],"published":{"date-parts":[[2007,7]]}}}